Page last updated: 2024-10-25

cilostazol and Hyperaldosteronism

cilostazol has been researched along with Hyperaldosteronism in 1 studies

Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.

Research Excerpts

ExcerptRelevanceReference
"We report a case of obvious pseudoaldosteronism which occurred after the additional administration of cilostazol against arteriosclerosis obliterans (ASO) for bilateral legs in a 65 year-old man patient who had safely received glycyrrhizin for the previous ten years."7.74Pseudoaldosteronism caused by combined administration of cilostazol and glycyrrhizin. ( Aoyagi, M; Inaba, N; Maeda, Y; Shiigai, T; Tanase, T, 2008)
"We report a case of obvious pseudoaldosteronism which occurred after the additional administration of cilostazol against arteriosclerosis obliterans (ASO) for bilateral legs in a 65 year-old man patient who had safely received glycyrrhizin for the previous ten years."3.74Pseudoaldosteronism caused by combined administration of cilostazol and glycyrrhizin. ( Aoyagi, M; Inaba, N; Maeda, Y; Shiigai, T; Tanase, T, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maeda, Y1
Inaba, N1
Aoyagi, M1
Tanase, T1
Shiigai, T1

Other Studies

1 other study available for cilostazol and Hyperaldosteronism

ArticleYear
Pseudoaldosteronism caused by combined administration of cilostazol and glycyrrhizin.
    Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:14

    Topics: Anti-Inflammatory Agents; Cilostazol; Drug Interactions; Glycyrrhizic Acid; Humans; Hyperaldosteroni

2008